Category: Health
US experts recommend Moderna booster for older and at-risk groups
An expert committee on Thursday recommended a booster dose of Moderna’s anti-Covid vaccine in the United States for certain at-risk groups, a month after making a [...] » More
WHO says it may be ‘last chance’ to find COVID origins
The World Health Organization said on Wednesday its newly formed advisory group on dangerous pathogens may be “our last chance” to determine the origins of the [...] » More
WHO panel on origins of new pathogens includes Wuhan probe members
The World Health Organization on Wednesday proposed 26 experts to form its new Scientific Advisory Group for the Origins of novel pathogens, including several who served on [...] » More
WHO recommends use of first malaria vaccine for children
The World Health Organization on Wednesday endorsed the RTS,S/AS01 malaria vaccine, the first against the mosquito-borne disease that kills more than 400,000 people a year, [...] » More
J&J asks US FDA to authorise booster shots of Covid vaccine
Drug maker Johnson & Johnson asked the US Federal Drug Administration (FDA) on Tuesday to authorise booster shots of its Covid-19 vaccine for people over the age of 18. [...] » More
Fauci Sees Pfiser Vaccine Approval For Young Kids By End Of October
Dr Anthony Fauci, the nation’s top infectious disease expert, said the country would “hopefully” begin vaccinating children as young as 5 by the end of [...] » More
COVID-19 pill developers aim to top Merck, Pfiser efforts
As Merck & Co (MRK.N) and Pfiser Inc (PFE.N) prepare to report clinical trial results for experimental COVID-19 antiviral pills, rivals are lining up with what they hope [...] » More
Pfiser starts large trial for anti-Covid pill
Pfiser said Monday it had begun a middle-to-late stage clinical trial of a pill to stave off Covid in people who are exposed to infection. Several companies are working on [...] » More
Pfiser launches mRNA flu vaccine trial
US pharmaceutical company Pfiser said Monday it had begun a clinical trial to test an influenza vaccine designed with the same mRNA technology behind its successful Covid-19 [...] » More
Covid treatments: What works, what doesn’t, what might
Overshadowed by the global push for vaccines, the search for treatments for Covid-19 has made steady if slower progress. Here is a look at what works, what might work, and [...] » More
Moderna CEO Predicts End Of COVID-19 Pandemic Within A Year
The chief executive of Moderna said Thursday he thinks the ongoing COVID-19 pandemic could be over within a year as vaccine production ramps up and doses are delivered around [...] » More
Nowhere left for Covid to go to mutate into a deadly variant, says Oxford vaccine creator
Covid is unlikely to mutate into a much deadlier variant because there “aren’t many places for the virus to go”, the lead scientist behind the Oxford [...] » More
Ebola: Profile of a dreaded killer
Ebola, which could reappear years later in survivors according to a study published by the journal Nature on Wednesday, has killed more than 15,000 people since 1976. Here is [...] » More
Ebola virus in survivors can trigger outbreaks years after infection
Ebola survivors can relapse and trigger outbreaks at least five years after infection, and long-term follow-up of former patients is needed to prevent devastating flare-ups, [...] » More
Israel booster jabs cutting severe Covid even as cases surge: experts
Israel’s programme of booster jabs has proved effective in reducing severe cases of Covid even as new infections hover near record highs, experts said, citing recent [...] » More
